Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines. (Q43643744)

From Wikidata

Jump to navigation Jump to search

scientific article published in July 2001

Language	Label	Description	Also known as
English	Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines.	scientific article published in July 2001

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11410862%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11410862%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

0 references

Fortunato Ciardiello

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11410862%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Giampaolo Tortora

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11410862%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11410862%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

R Caputo

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11410862%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

G Borriello

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11410862%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

E R Kandimalla

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11410862%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

S Agrawal

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11410862%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

J Mendelsohn

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11410862%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

A R Bianco

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11410862%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

language of work or name

0 references

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11410862%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11410862%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

93

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11410862%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11410862%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

172-178

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11410862%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1335

21 January 2018

Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily: role as anticancer agents

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1335

21 January 2018

Antisense oligonucleotides as therapeutic agents

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1335

21 January 2018

Antisense oligonucleotide inhibition of serine/threonine kinases: an innovative approach to cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1335

21 January 2018

Infection with a transforming growth factor alpha anti-sense retroviral expression vector reduces the in vitro growth and transformation of a human colon cancer cell line

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1335

21 January 2018

Amphiregulin anti-sense oligodeoxynucleotides inhibit growth and transformation of a human colon carcinoma cell line

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1335

21 January 2018

Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1335

21 January 2018

Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1335

21 January 2018

Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1335

21 January 2018

Transfection of anti-sense complementary DNA of human epidermal-growth-factor receptor attenuates the proliferation of human non-small-cell-lung-cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1335

21 January 2018

Antisense oligonucleotides to the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1335

21 January 2018

Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1335

21 January 2018

Antisense therapeutics: is it as simple as complementary base recognition?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1335

21 January 2018

Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1335

21 January 2018

Phase I clinical/pharmacokinetic and pharmacodynamic trial of the c-raf-1 antisense oligonucleotide ISIS 5132 (CGP 69846A).

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1335

21 January 2018

Phase I evaluation of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C-alpha, in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1335

21 January 2018

Chemosensitisation of malignant melanoma by BCL2 antisense therapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1335

21 January 2018

Epidermal growth factor expression in human colon and colon carcinomas: anti-sense epidermal growth factor receptor RNA down-regulates the proliferation of human colon cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1335

21 January 2018

EGF-related peptides are involved in the proliferation and survival of MDA-MB-468 human breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1335

21 January 2018

Epidermal growth factor receptor family and chemosensitization

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1335

21 January 2018

BCL-2 antisense therapy in patients with non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1335

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43643744&oldid=2102282466"